Richard Marlink, M.D.

Senior Advisor for Medical and Scientific Affairs of the Elizabeth Glaser Pediatric AIDS Foundation.

Dr. Richard Marlink oversees the Elizabeth Glaser Pediatric AIDS
Foundation’s efforts to expand global HIV/AIDS care and treatment
services, including antiretroviral treatment. Currently a professor at
the Harvard School of Public Health, Dr. Marlink was part of the team
that initially identified HIV-2, the second AIDS virus, and he helped
coordinate research concerning the clinical and biologic characteristics of both HIV-1 and HIV-2. In addition to a number of Botswana clinical studies in which he participates, Dr. Marlink is the principal investigator of Botswana's first large-scale antiretroviral treatment study.